Acción A042520 HANSBIOMED CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas HansBiomed Corporation

Acciones

A042520

KR7042520007

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 28/06/2024 		Varia. Cinco días. Varia. 1 de enero.
11.680 KRW +0,09 % Gráfico intradía de HansBiomed Corporation -5,04 % -20,44 %
14/05 HansBiomed Corporation informa de los resultados del segundo trimestre y los seis meses finalizados el 31 de marzo de 2024 CI
14/02 HansBiomed Corporation comunica los resultados del primer trimestre finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation(KOSDAQ:A042520) dropped from S&P Global BMI Index
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
HansBiomed Corporation Auditor Raises 'Going Concern' Doubt
HansBiomed Corporation announced that it has received KRW 15 billion in funding from Noh & Partners Corporation
Rebirth Biotechnology Co., Ltd announced that it has received CNY 20 million in funding from HansBiomed Corporation
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A042520
  4. Noticias HansBiomed Corporation
  5. Otros idiomas